INTI insider trading

Inhibitor Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
18
Last 90 days
1
Buys / sells
6% / 0%
Market cap

INTI insider activity at a glance

FilingIQ has scored 18 insider transactions for INTI since Dec 2, 2019. The most recent filing in our index is dated May 5, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on INTI insider trades is 47.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Frequently asked

How many insider trades does FilingIQ track for INTI?
FilingIQ tracks 18 Form 4 insider transactions for INTI (Inhibitor Therapeutics, Inc.), covering filings from Dec 2, 2019 onwards. 1 of those were filed in the last 90 days.
Are INTI insiders net buyers or net sellers?
Across the full Form 4 history for INTI, 1 transactions (6%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does INTI insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every INTI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.